That this House notes that November is Pancreatic Cancer Awareness Month across the UK and that pancreatic cancer remains the deadliest and the quickest killing cancer among common cancers; further notes that national data show that 75 per cent of people diagnosed will die within a year of diagnosis and only 30 per cent of people receive any active treatment; welcomes Pancreatic Cancer UK's Demand Faster Treatment campaign to treat people within 20 days of diagnosis by 2024; and urges the Government to take action to get more people with pancreatic cancer into treatment faster.

That this House notes that November is Pancreatic Cancer Awareness Month across the UK and that pancreatic cancer remains the deadliest and the quickest killing cancer among common cancers; further notes that national data show that 75 per cent of people diagnosed will die within a year of diagnosis and...

That this House congratulates the decision made by NHS England on World Diabetes Day to fund flash glucose monitoring for Type 1 diabetes patients across England from April 2019; commends all individuals and organisations that have continuously campaigned to end the postcode lottery for this life changing device which reduces the need for finger-prick blood tests and can make it much easier for the millions of people with diabetes to manage their condition; and urges the Government to allow access immediately and make Flash available to Type 2 diabetes patients as well.

That this House congratulates the decision made by NHS England on World Diabetes Day to fund flash glucose monitoring for Type 1 diabetes patients across England from April 2019; commends all individuals and organisations that have continuously campaigned to end the postcode lottery for this life changing device which reduces...

That this House recognises Spina Bifida and Hydrocephalus Awareness Week from 22 to 26 October 2018; commends the work of charities like Shine and SBH Scotland which provide specialist advice and support for spina bifida and hydrocephalus; notes that folic acid deficiency has led to life threatening birth defects in over 3,000 children since 1997; further notes that a 1991 study found that taking folic acid supplements before pregnancy reduced the risk of neural tube defects by 72 per cent; further recognises that that a study published earlier in 2018 concluded there is no need for an upper limit on folate and stated that every day in the UK, on average two women have a termination of pregnancy because of a neural tube defect and every week two women give birth to an affected child; and calls on the Government to follow the example of Australia, Canada, the US and 80 other countries across the world and legislate to implement the mandatory fortification of flour with folic acid to prevent neural tube defects including spina bifida, hydrocephalus and anencephaly.

That this House recognises Spina Bifida and Hydrocephalus Awareness Week from 22 to 26 October 2018; commends the work of charities like Shine and SBH Scotland which provide specialist advice and support for spina bifida and hydrocephalus; notes that folic acid deficiency has led to life threatening birth defects in...

That this House notes that November is Pancreatic Cancer Awareness Month across the UK and that 16 November 2017 is designated World Pancreatic Cancer Day; congratulates all pancreatic cancer charities and their supporters on their activities to raise awareness of the disease during November, including the joint Purple Lights initiative, which aims to light up as many public landmarks as possible throughout the month; recognises that pancreatic cancer is the fifth largest cause of cancer deaths in the UK; acknowledges that the disease has the lowest five-year survival rate of the 21 most common cancers at less than seven per cent, a figure which has increased only four per cent over the last 40 years; further notes that a 2017 poll commissioned by Pancreatic Cancer UK found that 64 per cent of people cannot name a single symptom of pancreatic cancer; and urges the Government to take action to deliver long-overdue improvements to pancreatic cancer awareness, diagnosis, treatment, care and research.

That this House notes that November is Pancreatic Cancer Awareness Month across the UK and that 16 November 2017 is designated World Pancreatic Cancer Day; congratulates all pancreatic cancer charities and their supporters on their activities to raise awareness of the disease during November, including the joint Purple Lights initiative,...

That this House is aware that lung disease is the third biggest killer in the UK, affecting over 12 million people at an annual cost of billions of pounds to the public purse; is alarmed by recent figures which reveal that mortality rates have not improved in the last 10 years with the UK now suffering the worst levels in Europe of diseases such as asthma, lung cancer, COPD, Idiopathic pulmonary fibrosis (IPF) and mesothelioma; recognises the work of the British Lung Foundation in its fight to highlight this issue in its report, Battle For Breath, and calls on the Government to support its conclusions that there is a desperate need to establish an independent taskforce to produce a five year strategy to improve outcomes for patients and support the NHS in its quest to dramatically improve the present situation.

That this House is aware that lung disease is the third biggest killer in the UK, affecting over 12 million people at an annual cost of billions of pounds to the public purse; is alarmed by recent figures which reveal that mortality rates have not improved in the last 10...

That this House notes that November is Pancreatic Cancer Awareness Month across the UK and that 17 November 2016 is designated World Pancreatic Cancer Day; congratulates all pancreatic cancer charities and their supporters for their activities to raise awareness of the disease during November, including the joint Purple Light initiative, which aims to light up as many public landmarks as possible throughout the month; recognises that pancreatic cancer is the fifth largest cause of cancer deaths in the UK; acknowledges that the disease has the worst five-year survival rate of the 21 most common cancers at five per cent, a figure which has hardly changed over the last 40 years; further notes that a recent poll commissioned by Pancreatic Cancer UK found that 74 per cent of people cannot name a single symptom of pancreatic cancer; and urges the Government to take action to deliver long-overdue improvements to pancreatic cancer awareness, diagnosis, treatment, care and research.

That this House notes that November is Pancreatic Cancer Awareness Month across the UK and that 17 November 2016 is designated World Pancreatic Cancer Day; congratulates all pancreatic cancer charities and their supporters for their activities to raise awareness of the disease during November, including the joint Purple Light initiative,...

That this House welcomes Stand Up To Cancer 2016 fundraising partnership between Cancer Research UK and public service broadcaster Channel 4; recognises that one in two people in the UK will be affected by cancer in their lifetime; notes the importance of Cancer Research UK's translational research, with clinical trials which turn scientific breakthroughs into practical new cancer treatments and tests; further notes that £16 million has been raised so far by the campaign this year and that more than £40 million has been raised through the Stand Up To Cancer and Channel 4 partnership in the UK to date, resulting in 30 funded trials and projects, involving more than 9,000 cancer patients; and pledges its support for Stand Up To Cancer 2016.

That this House welcomes Stand Up To Cancer 2016 fundraising partnership between Cancer Research UK and public service broadcaster Channel 4; recognises that one in two people in the UK will be affected by cancer in their lifetime; notes the importance of Cancer Research UK's translational research, with clinical trials...

That this House notes the growing concern from medical professionals and clinical experts regarding the lack of comprehensive care for people suffering from chronic pain and, in some cases, the harmful and unhelpful purchases of repeated over-the-counter opioids to treat them; observes that 40 per cent of British adults surveyed by the Chronic Pain Policy Coalition have taken opioid painkillers consecutively for three days or longer, despite NICE guidelines recommending that they should be taken for three days as a maximum; understands that there is a lack of awareness regarding the addictive quality of opioids, alternative treatments and the effect on mental health of poorly-managed chronic pain, including depression and anxiety; and calls on the Government to work with GPs, clinical commissioning groups and key stakeholder groups to increase the number of people receiving annual checks as well as care plans which will reduce avoidable GP appointments, visits to accident and emergency departments and prescription charges.

That this House notes the growing concern from medical professionals and clinical experts regarding the lack of comprehensive care for people suffering from chronic pain and, in some cases, the harmful and unhelpful purchases of repeated over-the-counter opioids to treat them; observes that 40 per cent of British adults surveyed...

That this House notes that NICE has failed to approve the anti-cancer drug Nivolumab for use in England, whereas the drug is already being prescribed in Scotland; further notes that Nivolumab is known as the wonder drug by many clinicians due to its success; congratulates Terri Robson of Leyton and her family and supporters for raising more than 170,000 signatures on a petition calling for Nivolumab to be prescribed in England; and calls on NICE to review urgently its decision for the sake of thousands of patients who are desperately in need of Nivolumab.

That this House notes that NICE has failed to approve the anti-cancer drug Nivolumab for use in England, whereas the drug is already being prescribed in Scotland; further notes that Nivolumab is known as the wonder drug by many clinicians due to its success; congratulates Terri Robson of Leyton and...

That this House is aware that there are currently over 1 to 2 million stroke survivors in the UK, with about 2,000 of them in each parliamentary constituency, and over half suffering a disability as a result of their stroke, a condition which remains the fourth biggest killer in the UK; supports the Stroke Association's call on the Government to either renew the now nine year old stroke strategy which ends in 2017 or produce a new one for the illness in England; and believes such a policy must include the reorganisation of acute stroke care, improvement of post acute care, tackling regional variations in the quality of care, delivery of six months assessments, improved psychological support, targets for local commissioners and the full utilisations of new treatments.

That this House is aware that there are currently over 1 to 2 million stroke survivors in the UK, with about 2,000 of them in each parliamentary constituency, and over half suffering a disability as a result of their stroke, a condition which remains the fourth biggest killer in the...

That this House is concerned about the decision of the Department of Work and Pensions to include a requirement that relatives of deceased mineworkers be required to accompany any application with a Grant of Probate, the purpose of doing so to apparently reduce the overall amount of compensation payable under the Coal Workers Pneumoconiosis Scheme 1974 to recipients; believes such a practice to be despicable and a direct attack on carers who have devoted much of their lives looking after loved ones terminally damaged by their employment; and calls upon the Government to end forthwith such demeaning practices.

That this House is concerned about the decision of the Department of Work and Pensions to include a requirement that relatives of deceased mineworkers be required to accompany any application with a Grant of Probate, the purpose of doing so to apparently reduce the overall amount of compensation payable under...

That this House congratulates Diabetes UK for organising Diabetes Week 2016; acknowledges hon. Members of this House, the hon. Member for Harborough, Oadby and Wigston, the hon. Member for East Renfrewshire, the hon. Member for Portsmouth South, the hon. Member for Eddisbury, the hon. Member for Hazel Grove and the hon. Member for Kensington in joining with the All Party Parliamentary Group for Diabetes in its diabetes testing in pharmacies campaign; notes that 12 per cent of adults with diabetes in the UK are undiagnosed; further acknowledges the importance of easily accessible and early testing for the prevention of type 2 diabetes; and urges all hon. Members to promote diabetes awareness and encourage testing in their constituency during Diabetes Week 2016 and to take the test themselves.

That this House congratulates Diabetes UK for organising Diabetes Week 2016; acknowledges hon. Members of this House, the hon. Member for Harborough, Oadby and Wigston, the hon. Member for East Renfrewshire, the hon. Member for Portsmouth South, the hon. Member for Eddisbury, the hon. Member for Hazel Grove and the...

That this House notes that hepatitis C is a major cause of premature death from liver disease; further notes that the World Health Organisation has compared hepatitis C to a viral time bomb; acknowledges that the condition is entirely curable by effective new treatments; and calls on the Government to prioritise the elimination of hepatitis C by implementing national improvement measures as a matter of urgency.

That this House notes that hepatitis C is a major cause of premature death from liver disease; further notes that the World Health Organisation has compared hepatitis C to a viral time bomb; acknowledges that the condition is entirely curable by effective new treatments; and calls on the Government to...

That this House welcomes the 10 point Meningitis Action Plan put forward by Meningitis Now and Meningitis Research Foundation in light of the meningitis petition signed by over 823,000 people; notes the charities' concerns regarding the cost-effectiveness framework and adolescent carriage/intervention study; further notes the weight of evidence given to the Petitions Committee in conjunction with the Health Committee; supports the request for the Joint Committee on Vaccination and Immunisation to consider a one-off catch-up vaccination programme for children under five years old and utilise a fairer cost-effectiveness framework; and encourages the Secretary of State for Health to expedite implementation of the 10 point plan put forward by both charities.

That this House welcomes the 10 point Meningitis Action Plan put forward by Meningitis Now and Meningitis Research Foundation in light of the meningitis petition signed by over 823,000 people; notes the charities' concerns regarding the cost-effectiveness framework and adolescent carriage/intervention study; further notes the weight of evidence given to...

That this House is aware that sufferers of epilepsy carry a greater risk of premature death, with many experiencing other serious health conditions in their lives; recalls that the last National Sentinel Audit took place 14 years ago and identified many deficiencies in the care of 54 per cent of adults where epilepsy was the probable cause of their deaths; notes, however, that since this important survey was undertaken, no adequate action to halt these alarming figures has been forthcoming, with the Department of Health even removing two of the main epilepsy indicators used to evaluate by local commissioners; and believes it to be urgent that the Government immediately commissions a new national audit to identify the main causes of these avoidable deaths, to eliminate any regional disparities found and to refocus efforts and resources to greater effect.

That this House is aware that sufferers of epilepsy carry a greater risk of premature death, with many experiencing other serious health conditions in their lives; recalls that the last National Sentinel Audit took place 14 years ago and identified many deficiencies in the care of 54 per cent of...

That this House notes that hepatitis C is a major cause of the rising number of avoidable premature deaths from liver disease; further notes that hepatitis C predominantly affects the most disadvantaged in society and remains a pressing public health concern; acknowledges the availability of highly-effective new treatments that can cure the disease in almost everyone; recognises that the complexity of community pathways for hepatitis C results in local bodies requiring guidance on responsibilities and actions to treat the virus; understands that a hepatitis C improvement framework has been expected for over 12 months; and calls on the Government, NHS England and Public Health England to work towards eliminating hepatitis C as a major public health concern by publishing a national improvement framework as a matter of urgency.

That this House notes that hepatitis C is a major cause of the rising number of avoidable premature deaths from liver disease; further notes that hepatitis C predominantly affects the most disadvantaged in society and remains a pressing public health concern; acknowledges the availability of highly-effective new treatments that can...

That this House notes with concern that mesothelioma is an invasive form of lung cancer caused primarily by prior exposure to asbestos; recognises that there is currently no cure for this devastating disease and that mesothelioma patients frequently have a very short life expectancy and experience complex and debilitating symptoms; further notes that the UK has the highest rate of the disease in the world and that over the next 30 years more than 50,000 people will die of mesothelioma in the UK unless new treatments are found; believes that investment in research into the causes and potential cures for mesothelioma is desperately needed; and calls on the Government to facilitate the establishment of a long-term sustainable mesothelioma research scheme funded by the insurance.

That this House notes with concern that mesothelioma is an invasive form of lung cancer caused primarily by prior exposure to asbestos; recognises that there is currently no cure for this devastating disease and that mesothelioma patients frequently have a very short life expectancy and experience complex and debilitating symptoms;...

That this House is aware that the World Health Organisation (WHO) is shortly to discuss reforms of the research and development of medicines worldwide; notes that examples of failures in medicine include lack of new treatments for conditions such as tuberculosis and other so-called diseases of poverty, and that those suffering life threatening conditions like cancer being unable to afford the treatments needed to survive; and further notes the WHO has created a consultative export group (CEG) whose remit is to prepare a new international agreement which will create alternatives to market-only based incentives for pharmaceutical companies to produce new medicines, prioritise health research according to need rather than profit and establish a pooled fund for research and development to be financed by a levy of 0.01 per cent of gross domestic product to develop new treatments.

That this House is aware that the World Health Organisation (WHO) is shortly to discuss reforms of the research and development of medicines worldwide; notes that examples of failures in medicine include lack of new treatments for conditions such as tuberculosis and other so-called diseases of poverty, and that those...

That this House recalls that the Government pledged to help end polio by agreeing to support the Global Polio Eradication Initiative, supporting the many world health organisations who have been battling to beat the illness throughout the Third World; believes that with the successes gained there is now a chance to largely confine polio to medical history books; and calls on the Government to keep promises made and continue to support whatever measures it takes to eradicate this dreadful, terrible disease.

That this House recalls that the Government pledged to help end polio by agreeing to support the Global Polio Eradication Initiative, supporting the many world health organisations who have been battling to beat the illness throughout the Third World; believes that with the successes gained there is now a chance...

That this House is aware that mesothelioma is a particularly aggressive form of terminal cancer caused by exposure to asbestos; recalls that in 2014 the Government established a scheme to pay lump sum payments to civilians who had contracted the illness but were unable to trace a liable employer or insurance provider, and that under its terms sufferers stand to receive significant sums in compensation; notes in contrast that members of the armed forces contracting the illness are today likely to receive considerably less because of the anomaly that they can neither sue their employer nor get redress for any illness sustained before 1987; and calls on the Government to take action to cease forthwith such an unfair approach, which flies in the face of the Armed Forces Covenant.

That this House is aware that mesothelioma is a particularly aggressive form of terminal cancer caused by exposure to asbestos; recalls that in 2014 the Government established a scheme to pay lump sum payments to civilians who had contracted the illness but were unable to trace a liable employer or...